COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: Correspondence

Detalles Bibliográficos
Autores principales: Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of British Infection Association. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736279/
https://www.ncbi.nlm.nih.gov/pubmed/35018340
http://dx.doi.org/10.1016/j.clinpr.2021.100132
_version_ 1784628433516494848
author Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_facet Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_sort Mungmunpuntipantip, Rujittika
collection PubMed
description
format Online
Article
Text
id pubmed-8736279
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier Ltd on behalf of British Infection Association.
record_format MEDLINE/PubMed
spelling pubmed-87362792022-01-07 COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: Correspondence Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Clin Infect Pract Article The Author(s). Published by Elsevier Ltd on behalf of British Infection Association. 2022-01 2022-01-07 /pmc/articles/PMC8736279/ /pubmed/35018340 http://dx.doi.org/10.1016/j.clinpr.2021.100132 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: Correspondence
title COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: Correspondence
title_full COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: Correspondence
title_fullStr COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: Correspondence
title_full_unstemmed COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: Correspondence
title_short COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: Correspondence
title_sort covid-19 with a heavily mutated variant in a multiple myeloma after vaccination: correspondence
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736279/
https://www.ncbi.nlm.nih.gov/pubmed/35018340
http://dx.doi.org/10.1016/j.clinpr.2021.100132
work_keys_str_mv AT mungmunpuntipantiprujittika covid19withaheavilymutatedvariantinamultiplemyelomaaftervaccinationcorrespondence
AT wiwanitkitviroj covid19withaheavilymutatedvariantinamultiplemyelomaaftervaccinationcorrespondence

Ejemplares similares